Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
BiopSense Oy
OY
Active
Y-tunnus 2958574-3
Eeronkatu 10, 40720
Jyväskylä
Diagnostic imaging services and medical laboratory activities
·
NACE 8691
Est. 2018 · 7 years old
11 employees
www.biopsense.com
Share
Finland
/
Companies
/
Diagnostic imaging services and medical laboratory activities
/
BiopSense Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
6M
5M
3M
2M
0M
2021: 5M
5M
2021
2022: 1M (-80% vs 2021)
1M
-80%
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
EUR millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 0M (-100% vs 2021)
0M
-100%
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
117
61
41
704
4 636
Staff expenses
−409
−411
−712
−693
−850
EBITDA
−299
−314
−199
−378
994
Depreciation & amort.
−51
−60
−73
−68
−39
EBIT
−350
−375
−272
−447
955
Net financials
−87
−21
−0
−3
−6
Profit before tax
−437
−396
−272
−450
949
Tax
−0
−0
−0
5
169
Net profit
−437
−396
−272
−455
780
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
2 452
1 890
916
1 769
954
Equity
470
582
128
169
677
Long-term debt
1 649
1 017
0
—
1
Short-term debt
333
291
788
1 600
276
Total debt
1 982
1 307
788
1 600
277
Financial ratios
5-year trend
EBITDA margin
−255,3 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2025
Equity ratio
19,2 %
This company
38,2 %
Market median
This company
Market median
50% below market
2021
2025
Return on equity
−93,0 %
This company
18,4 %
Market median
This company
Market median
605% below market
2021
2025
Net profit margin
−373,6 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2021
2025
Asset turnover
0,05×
This company
1,12×
Market median
This company
Market median
96% below market
2021
2025
Debt / equity
4,21×
This company
0,62×
Market median
This company
Market median
579% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2024-12-01 – 2025-11-30
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-12-01 – 2024-11-30
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-12-01 – 2023-11-30
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-12-01 – 2022-11-30
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-06-01 – 2021-11-30
View
PDF
More on BiopSense Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
